hrp0082p1-d1-236 | Thyroid | ESPE2014
Trarbach Ericka B
, Shinzato Amanda
, Lin Chin J
, Marui Suemi
, Lerario Antonio M
Background: Differentiating potentially malignant thyroid nodules among those undetermined by cytology avoid unnecessary surgical procedures. Aberrant DNA methylation is ubiquitous in human cancers, including thyroid tumors. Biomarkers based on methylation profiles have been successfully used to diagnose early stage malignancy in many human cancers.Objective and hypotheses: To determine the genome-wide promoter methylation status of cytologically indeter...